Literature DB >> 31735081

Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.

Sytze P Rensma1,2, Thomas T van Sloten1,2, Alfons J H M Houben1,2, Sebastian Köhler3, Martin P J van Boxtel3,4, Tos T J M Berendschot5, Jacobus F A Jansen3,6,7, Frans R J Verhey3,4, Abraham A Kroon1,2, Annemarie Koster8,9, Walter H Backes3,6, Nicolaas Schaper1,2,9, Geert-Jan Dinant9, Casper G Schalkwijk2, Ronald M A Henry1,2,10, Elze M L Wolfs2, Mike J A van Heumen2, Miranda T Schram1,2,10, Coen D A Stehouwer1,2.   

Abstract

Microvascular dysfunction may be associated with worse cognitive performance. Most previous studies did not adjust for important confounders, evaluated only individual measures of microvascular dysfunction, and showed inconsistent results. We evaluated the association between a comprehensive set of measures of microvascular dysfunction and cognitive performance in the population-based Maastricht Study. We used cross-sectional data including 3011 participants (age 59.5±8.2; 48.9% women; 26.5% type 2 diabetes mellitus [oversampled by design]). Measures of microvascular dysfunction included magnetic resonance imaging features of cerebral small vessel disease, plasma biomarkers of microvascular dysfunction, albuminuria, flicker light-induced retinal arteriolar and venular dilation response and heat-induced skin hyperemia. These measures were summarized into a microvascular dysfunction composite score. Cognitive domains assessed were memory, processing speed, and executive function. A cognitive function score was calculated as the sum of the scores on these 3 cognitive domains. The microvascular dysfunction score was associated with a worse cognitive function score (standardized β, -0.087 [95% CI, -0.127 to -0.047]), independent of age, education level, sex, type 2 diabetes mellitus, smoking, alcohol use, hypertension, total/HDL (high-density lipoprotein) cholesterol ratio, triglycerides, lipid-modifying medication, prior cardiovascular disease, depression and plasma biomarkers of low-grade inflammation. The fully adjusted β-coefficient of the association between the microvascular dysfunction score and the cognitive function score was equivalent to 2 (range, 1-3) years of aging for each SD higher microvascular dysfunction score. The microvascular dysfunction score was associated with worse memory and processing speed but not with worse executive function. The present study shows that microvascular dysfunction is associated with worse cognitive performance.

Entities:  

Keywords:  blood pressure; cerebral small vessel disease; cognition; dilation; hyperemia; hypertension; microcirculation

Year:  2019        PMID: 31735081     DOI: 10.1161/HYPERTENSIONAHA.119.13023

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

1.  Cystatin C, cognition, and brain MRI findings in 90+-year-olds.

Authors:  Wei Ling Lau; Mark Fisher; Dana Greenia; David Floriolli; Evan Fletcher; Baljeet Singh; Seyed Ahmad Sajjadi; Maria M Corrada; Christina Whittle; Claudia Kawas; Annlia Paganini-Hill
Journal:  Neurobiol Aging       Date:  2020-04-29       Impact factor: 4.673

Review 2.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

3.  Inequalities in cognitive impairment among older adults in China and the associated social determinants: a decomposition approach.

Authors:  Qingwen Deng; Wenbin Liu
Journal:  Int J Equity Health       Date:  2021-03-19

Review 4.  Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.

Authors:  Amy R Nelson
Journal:  Front Aging Neurosci       Date:  2022-04-18       Impact factor: 5.702

5.  Measuring hyperemic response to light flicker stimulus using continuous laser speckle flowgraphy in mice.

Authors:  Michelle R Tamplin; Kimberly A Broadhurst; Anthony H Vitale; Ryuya Hashimoto; Randy H Kardon; Isabella M Grumbach
Journal:  Exp Eye Res       Date:  2022-01-17       Impact factor: 3.770

6.  Sex Differences in Large Artery Stiffness: Implications for Cerebrovascular Dysfunction and Alzheimer's Disease.

Authors:  Mackenzie N Kehmeier; Ashley E Walker
Journal:  Front Aging       Date:  2021-12-01

7.  Spot Urine Albumin Creatinine Ratio can be a Predictor of Cognitive Function in Type 2 Diabetes Mellitus.

Authors:  Deepak Kumar Panigrahi; Debasish Chaudhury
Journal:  Indian J Nephrol       Date:  2021-01-27

8.  Mapping the transcriptomic changes of endothelial compartment in human hippocampus across aging and mild cognitive impairment.

Authors:  Daniel V Guebel; Néstor V Torres; Ángel Acebes
Journal:  Biol Open       Date:  2021-05-17       Impact factor: 2.422

Review 9.  Diabetes, Albuminuria and the Kidney-Brain Axis.

Authors:  Diana Maria Ariton; Joan Jiménez-Balado; Olga Maisterra; Francesc Pujadas; María José Soler; Pilar Delgado
Journal:  J Clin Med       Date:  2021-05-27       Impact factor: 4.241

Review 10.  Metabolic Syndrome, Cognitive Impairment and the Role of Diet: A Narrative Review.

Authors:  Matina Kouvari; Nathan M D'Cunha; Nikolaj Travica; Domenico Sergi; Manja Zec; Wolfgang Marx; Nenad Naumovski
Journal:  Nutrients       Date:  2022-01-13       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.